Predicting Diabetes Onset 19 years In advance 20 May 2022 Type 2 diabetes could be predicted up to 19 years in advance, claim researchers at Lund University in Sweden. The researchers identified high levels of a particular protein in the blood, called follistatin, as a predictor of a person’s likelihood of developing type 2 diabetes (regardless of other risk factors). “This study shows that follistatin has the potential to become an important biomarker to predict future type 2 diabetes, and it also brings us one step closer to the understanding of the mechanisms behind the disease,” said Dr. Yang De Marinis, associate professor at Lund University and lead author of the study. Follistatin helps break down body fat, which in turn increases fat build-up in the liver that can lead to fatty liver and type 2 diabetes. Since follistatin levels fluctuate according to food consumption and activity levels, Dr. Yang De Marinis emphasises the usual advice for preventing diabetes: “Balanced meals, eat[ing] healthy and regular exercise.” Next, the team are looking to develop a diagnostic tool using artificial intelligence that could assess a person’s blood and determine a ‘risk score’ for diabetes based on follistatin (and other biomarker) levels. The full findings of this follistatin study can be accessed Key Messages Researchers in Sweden discover that type 2 diabetes could be predicted up to 19 years in advance (regardless of age, weight, or activity levels) by measuring levels of a blood protein called follistatin.Follistatin helps break down body fat, which in turn increases fat build-up in the liver that can lead to fatty liver and type 2 diabetes. Follistatin levels fluctuate according to food consumption and activity levels, so it is suggested to follow healthy eating and exercise recommendations to prevent diabetes onset.Next, researchers are hoping to develop an AI-generated diagnostic tool using follistatin levels as a measurement for diabetes susceptibility.
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading
Blog 30 April 2026 Ultra-processed foods. What are they and how do they impact diabetes? It’s no secret that eating foods that are high in unhealthy fats, salt and sugar may be harmful to our... Continue Reading